BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 204 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.8%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $266,638,000 | +4.9% | 1,763,828 | +1.1% | 0.02% | +13.3% |
Q2 2022 | $254,271,000 | +29.5% | 1,745,046 | +5.4% | 0.02% | +50.0% |
Q1 2022 | $196,332,000 | -13.5% | 1,655,834 | +0.5% | 0.01% | -9.1% |
Q4 2021 | $227,069,000 | +10.1% | 1,647,694 | +11.0% | 0.01% | 0.0% |
Q3 2021 | $206,272,000 | +43.5% | 1,484,930 | +0.3% | 0.01% | +37.5% |
Q2 2021 | $143,733,000 | +37.0% | 1,480,567 | -3.5% | 0.01% | +33.3% |
Q1 2021 | $104,900,000 | -26.8% | 1,534,744 | -8.2% | 0.01% | -33.3% |
Q4 2020 | $143,303,000 | +24.3% | 1,671,949 | -5.7% | 0.01% | +12.5% |
Q3 2020 | $115,274,000 | -11.0% | 1,773,172 | +0.1% | 0.01% | -11.1% |
Q2 2020 | $129,457,000 | +92.5% | 1,770,709 | -10.4% | 0.01% | +50.0% |
Q1 2020 | $67,241,000 | -35.4% | 1,975,941 | +3.4% | 0.01% | -14.3% |
Q4 2019 | $104,057,000 | +22.0% | 1,911,408 | -6.5% | 0.01% | +16.7% |
Q3 2019 | $85,315,000 | +22.7% | 2,044,943 | +28.8% | 0.01% | +20.0% |
Q2 2019 | $69,537,000 | +0.9% | 1,587,957 | +18.6% | 0.01% | 0.0% |
Q1 2019 | $68,921,000 | +84.3% | 1,339,048 | +32.4% | 0.01% | +66.7% |
Q4 2018 | $37,406,000 | -24.7% | 1,011,514 | -23.5% | 0.00% | -25.0% |
Q3 2018 | $49,655,000 | -15.7% | 1,322,355 | -11.3% | 0.00% | -20.0% |
Q2 2018 | $58,928,000 | +349.6% | 1,490,952 | +193.0% | 0.01% | +400.0% |
Q1 2018 | $13,106,000 | +171.7% | 508,803 | +184.5% | 0.00% | – |
Q4 2017 | $4,823,000 | -19.7% | 178,817 | +11.2% | 0.00% | -100.0% |
Q3 2017 | $6,009,000 | +104.8% | 160,775 | +37.2% | 0.00% | – |
Q2 2017 | $2,934,000 | – | 117,212 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 1,111,111 | $154,344,000 | 72.03% |
Knoll Capital Management, LLC | 856,844 | $119,024,000 | 59.36% |
ORACLE INVESTMENT MANAGEMENT INC | 2,124,055 | $295,053,000 | 36.73% |
ARS Investment Partners, LLC | 466,668 | $64,825,000 | 6.49% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 365,373 | $50,754,000 | 6.18% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $24,490,000 | 5.91% |
SILVERARC CAPITAL MANAGEMENT, LLC | 61,897 | $8,598,000 | 4.86% |
DAFNA Capital Management LLC | 88,100 | $12,238,000 | 3.25% |
Avidity Partners Management LP | 934,200 | $129,770,000 | 2.88% |
Eventide Asset Management | 1,325,000 | $184,056,000 | 2.43% |